Results: 1-23 |
Results: 23

Authors: Sirohi, B Powles, R Mehta, J Treleaven, J Raje, N Kulkarni, S Rudin, C Bhagwati, N Horton, C Saso, R Singhal, S Parikh, P
Citation: B. Sirohi et al., The implication of compromised renal function at presentation in myeloma -Similar outcome in Patients who receive high-dose therapy: A single-centerstudy of 251 previously untreated patients, MED ONCOL, 18(1), 2001, pp. 39-50

Authors: Sirohi, B Powles, R Kulkarni, S Rudin, C Saso, R Lal, R Singhal, S Mehta, J Horton, C Treleaven, J
Citation: B. Sirohi et al., Comparison of new patients with Bence-Jones, IgG and IgA myeloma receivingsequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria, BONE MAR TR, 28(1), 2001, pp. 29-37

Authors: Sirohi, B Powles, R Kulkarni, S Rudin, C Saso, R Rigg, A Horton, C Singhal, S Mehta, J Treleaven, J
Citation: B. Sirohi et al., Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myeloma, BR J CANC, 85(3), 2001, pp. 325-332

Authors: Rege, K Swansbury, GJ Atra, AA Horton, C Min, T Dainton, MG Matutes, E Durosinmi, M Treleaven, JG Powles, RL Catovsky, D
Citation: K. Rege et al., Disease features in acute myeloid leukemia with t(8;21)(q22;g22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival, LEUK LYMPH, 40(1-2), 2000, pp. 67-77

Authors: Horton, C
Citation: C. Horton, Ben Jonson's Antimasques: A history of growth and decline, PARERGON, 17(2), 2000, pp. 233-235

Authors: Singhal, S Powles, R Treleaven, J Kulkarni, S Sirohi, B Horton, C Millar, B Shepherd, V Tait, D Saso, R Rowland, A Long, S Mehta, J
Citation: S. Singhal et al., A low CD34(+) cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34(+) cells/kg be considered the minimum threshold?, BONE MAR TR, 26(5), 2000, pp. 489-496

Authors: Powles, R Sirohi, B Kulkarni, S Bhagwati, N Saso, R Raje, N Horton, C Singhal, S Mehta, J Treleaven, J
Citation: R. Powles et al., Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients, BONE MAR TR, 25(9), 2000, pp. 949-956

Authors: Vaidya, SJ Atra, A Bahl, S Pinkerton, CR Calvagna, V Horton, C Milan, S Shepherd, V Brain, C Treleaven, J Powles, R Tait, D Meller, ST
Citation: Sj. Vaidya et al., Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up, BONE MAR TR, 25(6), 2000, pp. 599-603

Authors: Singhal, S Powles, R Kulkarni, S Treleaven, J Sirohi, B Millar, B Shepherd, V Saso, R Rowland, A Long, S Cabral, S Horton, C Mehta, J
Citation: S. Singhal et al., Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation, BONE MAR TR, 25(5), 2000, pp. 501-505

Authors: Sirohi, B Powles, R Treleaven, J Mainwaring, P Kulkarni, S Pandha, H Bhagwati, N Horton, C Singhal, S Mehta, J
Citation: B. Sirohi et al., The role of autologous transplantation in patients with multiple myeloma aged 65 years and over, BONE MAR TR, 25(5), 2000, pp. 533-539

Authors: Kulkarni, S Powles, R Treleaven, J Singhal, S Horton, C Sirohi, B Bhagawati, N Tait, D Saso, R Killick, S Pinkerton, R Atra, A Meller, S Mehta, J
Citation: S. Kulkarni et al., Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years, BONE MAR TR, 25(4), 2000, pp. 365-370

Authors: Powles, R Mehta, J Kulkarni, S Treleaven, J Millar, B Marsden, J Shepherd, V Rowland, A Sirohi, B Tait, D Horton, C Long, S Singhal, S
Citation: R. Powles et al., Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial, LANCET, 355(9211), 2000, pp. 1231-1237

Authors: Kelly, RE Wenger, A Horton, C Nuss, D Croitoru, DP Pestian, JP
Citation: Re. Kelly et al., The effects of a pediatric unilateral inguinal hernia clinical pathway on quality and cost, J PED SURG, 35(7), 2000, pp. 1045-1048

Authors: Freundlich, A Horton, C Vilela, MF Sterling, M Ignatiev, A Neu, G Teisseire, M
Citation: A. Freundlich et al., Photoluminescence of GaAs grown by metallorganic molecular beam epitaxy inspace ultra-vacuum, J CRYST GR, 209(2-3), 2000, pp. 435-439

Authors: Oakland, T Joyce, D Horton, C Glutting, J
Citation: T. Oakland et al., Temperament-based learning styles of identified gifted and nongifted students, GIFT CHILD, 44(3), 2000, pp. 183-189

Authors: Kulkarni, S Powles, R Treleaven, J Riley, U Singhal, S Horton, C Sirohi, B Bhagwati, N Meller, S Saso, R Mehta, J
Citation: S. Kulkarni et al., Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants, BLOOD, 95(12), 2000, pp. 3683-3686

Authors: Barnes, NR Stroud, PD Robinson, KE Horton, C Schreiner, AF
Citation: Nr. Barnes et al., 5,10,15,20-tetrakis(4-N-methylpyridyl)porphyrinato-palladium(II) as a differentiation probe for sensing binding modes with B-DNA duplexes: ElectronicMCD and CD spectra, BIOSPECTROS, 5(3), 1999, pp. 179-188

Authors: Singhal, S Powles, R Treleaven, J Kulkarni, S Horton, C Mehta, J
Citation: S. Singhal et al., Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling, LEUK LYMPH, 34(3-4), 1999, pp. 287-294

Authors: Singhal, S Powles, R Treleaven, J Kulkarni, S Horton, C Mehta, J
Citation: S. Singhal et al., Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation, BONE MAR TR, 23(9), 1999, pp. 875-879

Authors: Kulkarni, S Powles, RL Treleaven, JG Singhal, S Saso, R Horton, C Killick, S Tait, D Ramiah, V Mehta, J
Citation: S. Kulkarni et al., Impact of previous high-dose therapy on outcome after allografting for multiple myeloma, BONE MAR TR, 23(7), 1999, pp. 675-680

Authors: Staprans, SI Dailey, PJ Rosenthal, A Horton, C Grant, RM Lerche, N Feinberg, MB
Citation: Si. Staprans et al., Simian immunodeficiency virus disease course is predicted by the extent ofvirus replication during primary infection, J VIROLOGY, 73(6), 1999, pp. 4829-4839

Authors: Sirohi, B Powles, R Mehta, J Raje, N Kulkarni, S Ramiah, V Saso, R Horton, C Bhagwati, N Singhal, S Treleaven, J
Citation: B. Sirohi et al., Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed diseaseentity with a new staging system, BR J HAEM, 107(3), 1999, pp. 656-666

Authors: Neu, G Teisseire, M Freundlich, A Horton, C Ignatiev, A
Citation: G. Neu et al., Donor-acceptor-pair spectroscopy of GaAs grown in space ultravacuum, APPL PHYS L, 74(22), 1999, pp. 3341-3343
Risultati: 1-23 |